О компании

Visible Genomics provides a clinically validated age-related macular degeneration (AMD) risk assessment. The company's comprehensive risk assessment provide advanced awareness of disease risk which will empower the patient and healthcare professional to make informed clinical and lifestyle decisions together, help slow or prevent disease, and provide greater access to more patients through affordable, easy, and understandable genetic risk testing.

US
Неизвестно
Не проверенная компания